From Financial Modeling Prep: 2025-04-23 10:03:00

Boston Scientific Corporation (NYSE:BSX) exceeded expectations with an EPS of $0.75, higher than the estimated $0.67. The company’s revenue for the quarter was $4.66 billion, surpassing the estimated $4.57 billion. Following this strong performance, Boston Scientific has raised its annual profit forecast for 2025 and seen a surge in its stock price.



Read more at Financial Modeling Prep:: Boston Scientific Corporation’s Impressive First Q…